ATE325884T1 - Verfahren zur einführung von genen in zielzellen mit hilfe von retroviren - Google Patents

Verfahren zur einführung von genen in zielzellen mit hilfe von retroviren

Info

Publication number: ATE325884T1
Authority: AT; Austria
Prior art keywords: target cells; retrovirus; retroviruses; effective amount; functional material
Prior art date: 1995-11-13

Application number

AT96937515T

Other languages

English (en)

Inventor

Kiyozo Asada

Takashi Uemori

Takashi Ueno

Nobuto Koyama

Kimikazu Hashino

Ikunoshiu Kato

Original Assignee

Takara Bio Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-13

Filing date

1996-11-07

Publication date

2006-06-15

1996-11-07 Application filed by Takara Bio Inc filed Critical Takara Bio Inc

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE325884T1 publication Critical patent/ATE325884T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- C12N9/1088—Glutathione transferase (2.5.1.18)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13045—Special targeting system for viral vectors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Plant Pathology (AREA)
Virology (AREA)
Cell Biology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT96937515T 1995-11-13 1996-11-07 Verfahren zur einführung von genen in zielzellen mit hilfe von retroviren ATE325884T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP29438295		1995-11-13
JP5184796		1996-03-08

Publications (1)

Publication Number	Publication Date
ATE325884T1 true ATE325884T1 (de)	2006-06-15

Family

ID=26392431

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96937515T ATE325884T1 (de)	1995-11-13	1996-11-07	Verfahren zur einführung von genen in zielzellen mit hilfe von retroviren

Country Status (13)

Country	Link
US (5)	US6472204B1 (de)
EP (1)	EP0870839B1 (de)
JP (1)	JP3343357B2 (de)
KR (2)	KR100353115B1 (de)
CN (1)	CN100390290C (de)
AT (1)	ATE325884T1 (de)
AU (1)	AU709831B2 (de)
CA (1)	CA2235629A1 (de)
DE (1)	DE69636122T2 (de)
EA (3)	EA003204B1 (de)
ES (1)	ES2259182T3 (de)
MX (1)	MX9803706A (de)
WO (1)	WO1997018318A1 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7083979B1 (en)	1994-03-25	2006-08-01	Indiana University Foundation	Methods for enhanced retroviral-mediated gene transfer
ATE445705T1 (de)	1995-06-15	2009-10-15	Crucell Holland Bv	Verpackungssysteme für humane rekombinante adenoviren zur gentherapie
AU720359B2 (en)	1995-09-29	2000-06-01	Indiana University Research And Technology Corporation	Methods for enhanced virus-mediated DNA transfer using molecules with virus- and cell-binding domains
TWI239352B (en) *	1997-07-23	2005-09-11	Takara Bio Inc	Gene transfer method with the use of serum-free medium
US6316692B1 (en) *	1997-11-14	2001-11-13	Cedars Sinai Medical Center	Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
AU4393899A (en) *	1998-07-01	2000-01-24	Takara Shuzo Co., Ltd.	Gene transfer methods
AU1458200A (en) *	1998-10-31	2000-05-22	University Of Medicine And Dentistry Of New Jersey	A myeloid precursor cell useful for gene therapy and for modulation of immune responses
DE60036929T2 (de) *	1999-03-23	2008-08-07	Takara Bio Inc., Otsu	Gentherapeutika
US7410941B1 (en)	1999-04-13	2008-08-12	The Kenneth S. Warren Institute, Inc.	Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
US7345019B1 (en)	1999-04-13	2008-03-18	The Kenneth S. Warren Institute, Inc.	Modulation of excitable tissue function by peripherally administered erythropoietin
US6855544B1 (en)	1999-04-15	2005-02-15	Crucell Holland B.V.	Recombinant protein production in a human cell
US8236561B2 (en) *	1999-04-15	2012-08-07	Crucell Holland B.V.	Efficient production of IgA in recombinant mammalian cells
US20050164386A1 (en) *	1999-04-15	2005-07-28	Uytdehaag Alphonsus G.	Overexpression of enzymes involved in post-translational protein modifications in human cells
US7604960B2 (en) *	1999-04-15	2009-10-20	Crucell Holland B.V.	Transient protein expression methods
US7297680B2 (en)	1999-04-15	2007-11-20	Crucell Holland B.V.	Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
US20050170463A1 (en) *	1999-04-15	2005-08-04	Abraham Bout	Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins
GB9912965D0 (en) *	1999-06-03	1999-08-04	Oxford Biomedica Ltd	In vivo selection method
AU5958000A (en) *	1999-07-08	2001-01-30	Connie Jean Eaves	Method to improve viral infection
US7521220B2 (en) *	1999-11-26	2009-04-21	Crucell Holland B.V.	Production of vaccines
US7527961B2 (en) *	1999-11-26	2009-05-05	Crucell Holland B.V.	Production of vaccines
US7192759B1 (en)	1999-11-26	2007-03-20	Crucell Holland B.V.	Production of vaccines
AU2001285263A1 (en)	2000-08-25	2002-03-13	The General Hospital Corporation	Selective precipitation of viruses
PA8536201A1 (es)	2000-12-29	2002-08-29	Kenneth S Warren Inst Inc	Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
US6531121B2 (en)	2000-12-29	2003-03-11	The Kenneth S. Warren Institute, Inc.	Protection and enhancement of erythropoietin-responsive cells, tissues and organs
US8742091B2 (en) *	2001-06-20	2014-06-03	Dainippon Sumitomo Pharma Co., Ltd.	Method of promoting nucleic acid transfer
JP2005052001A (ja) *	2001-07-05	2005-03-03	Takara Bio Inc	遺伝子治療剤
TWI315740B (de)	2001-08-15	2009-10-11	Takara Bio Inc
CN100547069C (zh) *	2001-12-07	2009-10-07	克鲁塞尔荷兰公司	病毒、病毒分离物和疫苗的生产
DE60335253D1 (de)	2002-03-25	2011-01-20	Takara Bio Inc	Verfahren zur produktion eines zytotoxischen lymphozyten
US20100143442A1 (en)	2003-02-05	2010-06-10	Queensland University Of Technology	Growth factor complexes and modulation of cell migration and growth
US20040219099A1 (en) *	2003-05-02	2004-11-04	Jasbir Sandhu	Method for the treatment of tumors
US20040220085A1 (en) *	2003-05-02	2004-11-04	Jasbir Sandhu	Compositions for nucleic acid delivery
KR101183770B1 (ko)	2003-05-09	2012-09-17	크루셀 홀란드 비.브이.	Ｅ1-불멸화된 세포의 배양물 및 이로부터 생성 수율을 증가시키기 위한 동일물의 배양 방법
EP1626992B1 (de) *	2003-05-23	2010-06-02	Crucell Holland B.V.	Herstellung von rekombinanten igm in den per.c6 zellen
FR2857598A1 (fr) *	2003-07-18	2005-01-21	Inst Nat Sante Rech Med	Composes anti-angiogeniques, composition pharmaceutique les comprenant, et leur utilisation
KR101331746B1 (ko)	2003-08-22	2013-11-20	다카라 바이오 가부시키가이샤	세포 상해성 림프구의 제조 방법
GB0410130D0 (en) *	2004-05-06	2004-06-09	Molmed Spa	Cell preparation
CN101031651B (zh) *	2004-09-29	2010-06-16	宝生物工程株式会社	用于产生反转录病毒载体的细胞
KR101174341B1 (ko)	2005-02-07	2012-08-16	다카라 바이오 가부시키가이샤	레트로 바이러스의 보존 방법
USD543589S1 (en) *	2005-04-28	2007-05-29	Michael Henley	Tag
KR20080016888A (ko)	2005-06-15	2008-02-22	다카라 바이오 가부시키가이샤	지방세포 또는 전구 지방세포로의 유전자 도입 방법
AU2006274438A1 (en) *	2005-07-29	2007-02-01	Australian Stem Cell Centre Limited	Compositions and methods for growth of pluripotent cells
JP5122957B2 (ja)	2005-08-16	2013-01-16	タカラバイオ株式会社	免疫不全ウイルス感染症の治療または予防のための核酸
EP1916302A4 (de)	2005-08-17	2009-10-21	Takara Bio Inc	Verfahren zur herstellung von lymphozyten
JP4741906B2 (ja) *	2005-08-31	2011-08-10	タカラバイオ株式会社	リンパ球の製造方法
WO2007040105A1 (ja)	2005-09-30	2007-04-12	Takara Bio Inc.	Ｔ細胞集団の製造方法
KR20090024782A (ko) *	2006-06-09	2009-03-09	다카라 바이오 가부시키가이샤	림프구의 제조 방법
JP5484897B2 (ja)	2007-04-20	2014-05-07	タカラバイオ株式会社	遺伝子治療のためのベクター
CN102046780A (zh)	2008-03-27	2011-05-04	宝生物工程株式会社	转染的细胞的生产方法
WO2010004989A1 (ja)	2008-07-07	2010-01-14	タカラバイオ株式会社	多能性幹細胞の製造方法
WO2010080032A2 (en) *	2009-01-09	2010-07-15	Stichting Het Nederlands Kanker Instituut	Bead-assisted viral transduction
EP2471901A4 (de)	2009-08-25	2013-06-26	Takara Bio Inc	Verfahren zur herstellung einer t-zellen-population unter verwendung von retinsäure
JP5792622B2 (ja)	2009-09-11	2015-10-14	タカラバイオ株式会社	ナチュラルキラー細胞の製造方法
JP2013511960A (ja) *	2009-11-30	2013-04-11	クイーンズランドユニバーシティオブテクノロジー	フィブロネクチン：増殖因子キメラ
EP2589656B8 (de) *	2010-06-30	2016-07-13	Takara Bio Inc.	Geneinsetzungsverfahren
US9228206B2 (en)	2010-06-30	2016-01-05	Takara Bio Inc.	Method for gene transfer
US9861681B2 (en)	2013-04-18	2018-01-09	The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases	Therapeutic compositions for neutralizing type I interferons, and methods of use
CN108474002B (zh)	2015-10-22	2023-05-23	朱诺治疗学有限公司	用于转导的方法、反应剂盒、反应剂和设备
JP7023228B2 (ja)	2016-07-29	2022-02-21	タカラバイオ株式会社	幹細胞の製造に用いられるフィブロネクチンフラグメント
US11524988B2 (en)	2016-09-19	2022-12-13	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Artificial antigen presenting cells for genetic engineering of immune cells
CN108103045B (zh) *	2016-11-25	2022-10-04	丰益(上海)生物技术研发中心有限公司	脂肪酶及其应用
JP6980209B2 (ja)	2017-02-22	2021-12-15	ルムスエルティーディー．	光ガイド光学アセンブリ
US12077590B2 (en) *	2017-02-22	2024-09-03	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Bispecific antibody for cancer immunotherapy
US12018276B2 (en)	2018-01-25	2024-06-25	Takara Bio Inc.	Lymphocyte production method
AU2020211092B2 (en)	2019-01-24	2023-05-11	Lumus Ltd.	Optical systems including LOE with three stage expansion
US12180444B2 (en)	2019-12-30	2024-12-31	Saint-Gobain Performance Plastics Corporation	Containers and methods for cell transduction
CN113444167B (zh) *	2021-07-15	2022-09-30	陕西巨子生物技术有限公司	重组人胶原蛋白多肽及其应用
CN114634984A (zh) *	2022-02-02	2022-06-17	复旦大学	一种脑胶质瘤生物标记物mlkl基因及其应用
WO2023213969A1 (en) *	2022-05-05	2023-11-09	Juno Therapeutics Gmbh	Viral-binding protein and related reagents, articles, and methods of use
CN114965839A (zh) *	2022-05-11	2022-08-30	朗肽生物制药股份有限公司	人碱性成纤维细胞生长因子的肽图分析方法
WO2024108221A1 (en) *	2022-11-18	2024-05-23	Saint-Gobain Performance Plastics Corporation	Aptamers, containers and methods for cell transduction
CN117603343B (zh) *	2024-01-19	2024-04-26	四川大学	阻断bFGF的胶原来源天然短肽及应用
CN117645664A (zh) *	2024-01-29	2024-03-05	英特菲尔(成都)生物制品有限责任公司	重组人纤连蛋白标准品及其制备方法、鉴定方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8516421D0 (en)	1985-06-28	1985-07-31	Biotechnology Interface Ltd	Fibronectins
JP2770926B2 (ja) *	1985-12-17	1998-07-02	サイナーゲンインコーポレーテッド	毛管内皮細胞プロテアーゼ合成、ｄｎａ合成および遊走を促進することの出来るヒト胎盤血管形成誘導因子
US4994559A (en)	1985-12-17	1991-02-19	Synergen, Inc.	Human basic fibroblast growth factor
US5026839A (en)	1985-12-17	1991-06-25	Synergen, Inc	DNA encoding a basic fibroblast growth factor
US5399346A (en)	1989-06-14	1995-03-21	The United States Of America As Represented By The Department Of Health And Human Services	Gene therapy
US5492890A (en)	1990-12-03	1996-02-20	The Scripps Research Institute	Polypeptides for promoting cell attachment
DE4110409C2 (de) *	1991-03-29	1999-05-27	Boehringer Ingelheim Int	Neue Protein-Polykation-Konjugate
JP2829405B2 (ja) *	1991-10-14	1998-11-25	寳酒造株式会社	機能性ポリペプチド
SE503225C2 (sv) *	1991-10-30	1996-04-22	Leif Lindholm Konsult Ab	Virus-antikroppskomplex för införing av virus i mammalieceller
CH685803A5 (fr) *	1992-06-09	1995-10-13	Francis Verdan	Bâton d'alun fixé dans un étui.
GB9223084D0 (en) *	1992-11-04	1992-12-16	Imp Cancer Res Tech	Compounds to target cells
US5686278A (en)	1994-03-25	1997-11-11	Indiana University Foundation	Methods for enhanced retrovirus-mediated gene transfer
JPH1029952A (ja)	1996-07-16	1998-02-03	Takara Shuzo Co Ltd	ヒト免疫不全ウイルス感染の制御用組成物および制御方法

1996
- 1996-11-07 EA EA200001110A patent/EA003204B1/ru not_active IP Right Cessation
- 1996-11-07 DE DE69636122T patent/DE69636122T2/de not_active Expired - Lifetime
- 1996-11-07 EA EA200200837A patent/EA004928B1/ru not_active IP Right Cessation
- 1996-11-07 ES ES96937515T patent/ES2259182T3/es not_active Expired - Lifetime
- 1996-11-07 JP JP51873197A patent/JP3343357B2/ja not_active Expired - Fee Related
- 1996-11-07 KR KR10-1998-0703457A patent/KR100353115B1/ko not_active IP Right Cessation
- 1996-11-07 EA EA199800369A patent/EA003195B1/ru not_active IP Right Cessation
- 1996-11-07 AU AU75058/96A patent/AU709831B2/en not_active Ceased
- 1996-11-07 US US08/809,156 patent/US6472204B1/en not_active Expired - Fee Related
- 1996-11-07 AT AT96937515T patent/ATE325884T1/de not_active IP Right Cessation
- 1996-11-07 CN CNB961996137A patent/CN100390290C/zh not_active Expired - Fee Related
- 1996-11-07 KR KR10-2001-7008355A patent/KR100395420B1/ko not_active IP Right Cessation
- 1996-11-07 WO PCT/JP1996/003254 patent/WO1997018318A1/ja active IP Right Grant
- 1996-11-07 EP EP96937515A patent/EP0870839B1/de not_active Expired - Lifetime
- 1996-11-07 CA CA002235629A patent/CA2235629A1/en not_active Abandoned
1998
- 1998-05-11 MX MX9803706A patent/MX9803706A/es unknown
1999
- 1999-08-02 US US09/366,009 patent/US6426042B1/en not_active Expired - Fee Related
2001
- 2001-02-02 US US09/775,964 patent/US6949623B2/en not_active Expired - Fee Related
2005
- 2005-07-14 US US11/181,091 patent/US7446170B2/en not_active Expired - Fee Related
2008
- 2008-09-30 US US12/241,581 patent/US7790849B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EA003204B1 (ru)	2003-02-27
CN100390290C (zh)	2008-05-28
CN1207774A (zh)	1999-02-10
EA200200837A1 (ru)	2002-12-26
EA199800369A1 (ru)	1998-12-24
DE69636122T2 (de)	2006-12-07
EA004928B1 (ru)	2004-10-28
US20030087437A1 (en)	2003-05-08
KR19990067446A (ko)	1999-08-16
WO1997018318A1 (en)	1997-05-22
EP0870839B1 (de)	2006-05-10
US20090209730A1 (en)	2009-08-20
MX9803706A (es)	1998-09-30
KR100395420B1 (ko)	2003-08-21
JP3343357B2 (ja)	2002-11-11
US6426042B1 (en)	2002-07-30
DE69636122D1 (de)	2006-06-14
AU709831B2 (en)	1999-09-09
US6472204B1 (en)	2002-10-29
US20060030046A1 (en)	2006-02-09
KR100353115B1 (ko)	2003-01-06
AU7505896A (en)	1997-06-05
US7446170B2 (en)	2008-11-04
US7790849B2 (en)	2010-09-07
US6949623B2 (en)	2005-09-27
EP0870839A1 (de)	1998-10-14
EA003195B1 (ru)	2003-02-27
EP0870839A4 (de)	2000-01-19
ES2259182T3 (es)	2006-09-16
CA2235629A1 (en)	1997-05-22
EA200001110A1 (ru)	2001-06-25

Publication	Publication Date	Title
ATE325884T1 (de)	2006-06-15	Verfahren zur einführung von genen in zielzellen mit hilfe von retroviren
ATE345682T1 (de)	2006-12-15	In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
AU2161501A (en)	2001-06-25	Immobilized single domain antigen-binding molecules
ATE260981T1 (de)	2004-03-15	Vektor und verfahren zur einbringung von nukleinsäure in sich nicht teilende zellen
AU2894289A (en)	1989-08-10	Domain-modified constant region antibodies
DE69636124D1 (de)	2006-06-14	Verfahren zum verbesserten virusvermittelten dns-transfer unter verwendung von molekülen mit virus- und zellbindenden domänen
DE3674642D1 (de)	1990-11-08	Zur modifizierung von bitumen verwendbare polymerzusammensetzungen und so modifizierte bitumenmassen.
EP1452540A3 (de)	2005-03-23	Molekularsequenz von Schweineretrovirus sowie Anwendungsverfahren
ATE227996T1 (de)	2002-12-15	Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod
DE69024447D1 (de)	1996-02-08	Induzierer einer tumorlysierenden Zelle, Verfahren und Gerät zur Induzierung tumorlysierender Zellen
ATE135745T1 (de)	1996-04-15	Immobilisierung von organischen makromolekülen oder biopolymeren in einer polymermembran
ATE70916T1 (de)	1992-01-15	Mit ueberzuegen versehene formkoerper zur bindung von bioaffinen substanzen.
WO1999058947A3 (en)	2000-02-03	Modulation of molecular interaction sites on rna and other biomolecules
DE59814359D1 (de)	2009-05-28	Mikrostrukturierter biosensor, verwendung des biosensors und verfahren zur immobilisierung von biokatalysatoren
DK0868511T3 (da)	2003-12-08	Genekspression af utrophin
DE69514415D1 (de)	2000-02-17	Verfahren zur Herstellung von Dioxazinverbindungen,damit gefärbte Materialien und Dioxazinverbindungen mit plattenartiger Kristallform.
DE69221826D1 (de)	1997-10-02	Aufgetragene Mikrokugeln
DE68923979D1 (de)	1995-10-05	Verfahren und Satz zur Identifizierung von Bakterien unter Verwendung von chromosomaler DNS.
ATE389727T1 (de)	2008-04-15	Modulatoren der expression von morphogenen und deren identifizierungsverfahren
DE69704885D1 (de)	2001-06-28	Zusammensetzung und Verfahren zur Leimung von flächigen Strukturen
RU2000106030A (ru)	2002-10-20	Способ воздействия на связывание p53 с геном-мишенью
DE59813114D1 (de)	2006-03-02	BK-RiV-Präparate zur Behandlung von proliferativen Zellerkrangungen
DE59607930D1 (de)	2001-11-22	Verfahren zur Einbringung von sich verjüngenden Pfählen, zugehörige Pfähle, und daraus hergestellte Gründungen und Fundamentbildungen
ATE55608T1 (de)	1990-09-15	Mittel und verfahren zur funktionalisierung von nukleinsaeuren.
DE3771490D1 (de)	1991-08-22	Filiformkorrosionsresistente primerzusammensetzung und methode zur verhuetung von filiformkorrosion.

Legal Events

Date	Code	Title	Description
2006-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties